Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use

By sjmartinez • April 6, 2025

Karpouzas GA, Gonzalez-Gay MA, Corrales A, Myasoedova E, Rantapää-Dahlqvist S, Sfikakis PP, Dessein P, Hitchon C, Pascual-Ramos V, Contreras-Yáñez I, Colunga-Pedraza IJ, Galarza-Delgado DA, Azpiri-Lopez JR, Semb AG, van Riel PLCM, Misra DP, Patrick D, Bridal Logstrup B, Hauge EM, Kitas G, Ormseth SR; for An inTernationAl Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA). Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use. RMD Open. 2025 Apr 5;11(2):e005464. doi: 10.1136/rmdopen-2025-005464. PMID: 40187772.

Tags: Anti-Citrullinated Protein Antibodies, Arthritis, biological therapy, cardiovascular diseases, Harbor UCLA, Publications, Rheumatoid, Rheumatology

Related Posts

Nondialytic Care vs Dialysis Transition on Hospitalization: Outcomes in Veterans With Advanced Chronic Kidney Disease

Rhee CM, Narasaki Y, Crowley ST, Kovesdy CP, Mukamel DB, You AS, Nguyen M, Siu MKM, Le L, Novoa A, Nguyen DV, Kalantar-Zadeh K. Nondialytic[...]

Prediction of the Statin responders with radiomics

Lee SE, Hong Y, Jung J, Sung JM, Andreini D, Al-Mallah MH, Budoff MJ, Cademartiri F, Chinnaiyan K, Choi JH, Chun EJ, Conte E, Gottlieb[...]

Continuous Glucose Monitoring and Mortality Risk Among U.S. Veterans Receiving Dialysis With Diabetes

Narasaki Y, Kalantar-Zadeh K, Zisman-Ilani Y, Klonoff DC, Kovesdy CP, Li Z, Jin A, Crowley S, M Belcher J, Gee P, Gin GE, Jordan M,[...]